PIM1 and B-cell chronic lymphocytic leukemia: Pim-1/− 2 are especially elevated in B-CLL patients and correlated with worse prognosis in B-CLL (elevated in Binet stage C) and B-CLL subtype, while Pim-1/2 expression was lower in patients achieving complete remission [126–129].